Aesthetics Chiropractic Care Colon Hydrotherapy EDTA Chelation IV Therapy Naturopathy Neurological Stress Reduction Nutritional Supplements Ozone Therapy Photodynamic Therapy SOT Therapy Testing Ultraviolet Blood Irradiation
About Us Our Team Contact Us
General Intake Form Aesthetics Intake Form Notice of Privacy Practices Nutritional Informed Consent Colon Hydrotherapy Intake Form

SOT Therapy

bigstock--174638674.jpg
 

SOT Therapy for Lyme Disease

SOT Therapy utilizes molecular building blocks that are found naturally in the patient’s body to treat a host of viruses and chronic unresponsive infections such as Lyme bacterial infections and co-infections.

 
DNA molecules

What is SOT (Supportive Oligonucleotide Therapy)?

SOT Therapy is a revolutionary treatment that is being utilized to treat cancer, a host of viruses and chronic unresponsive infections such as Lyme bacterial infections and co-infections. 

This breakthrough therapy works by creating short DNA or RNA segments that bind to and disable the target pathogen. It binds to the pathogen by creating a shutoff “key” that fits into the target “lock” portion of the pathogen or cancer cell. 

The “lock” is a specific section of the pathogen’s DNA or RNA that is responsible for an important function of the pathogen or cancer cell. The “key” binds to the “lock” and blocks the function and replication of the cell – thereby killing the pathogen or cancer cell and preventing its replication.

If a patient has multiple active infections, multiple SOT treatments will be needed for each infection.

Suctioning blue liquid

How Does SOT Work?

SOT therapy utilizes molecular building blocks that are found naturally in the patient’s body. Nucleotides are the molecules that form the structure of DNA and RNA.

SOT therapy creates an oligonucleotide that is complementary to a specific sequence for each gene.  It is designed to bind to this gene’s counterpart (mirror image) in the body, thus blocking its function.  It blocks a specific target at a very high rate – stopping the expression and transcription of a specific gene.

(SOT is not a drug and there is no gene manipulation.)

SOT terminates gene replication sequences, thus eradicating pathogens or cancerous cells from the body and preventing future lifecycles of these cells.

This therapy is tailored to each patient – and against the most active target for that individual. The SOT is complementary to a specific target inside cancer cells, viruses, and Lyme bacteria. Therefore, it is highly specific to these things only and will only work for the patient for whom it was made.

  • SOT induces rapid apoptosis (programmed cell death) in circulating tumor cells (CTCs), circulating cancer stem cells (CSCs), primary tumor cells, and metastatic tumors. In addition, it is able to cross the blood-brain barrier.

  • SOT treatment is available for the following viruses:

    • EBV (Epstein Barr Virus)
– CMV (Cytomegalovirus)
– Coxsackie Virus (Types A & B)
– VZV (Varicella Zoster Virus) (Chicken Pox, Shingles)
– HHV1/HSV1 (Oral Herpes Virus)

    • HHV2/HSV2 (Genital Herpes Virus)

    • HHV6 (Types A & B) (Human Herpes Virus 6)
– HPV (16/18) (Human Papillomavirus)

    • HPV (6/11) (Human Papillomavirus)
– HTLV1 (Human T-cell Lymphotropic Virus)
– HBV (Hepatitis B Virus)
– HCV (Hepatitis C Virus)
– HIV (Human Immunodeficiency Virus)

  • Borrelia mayonii – Borrelia burgdorferi – Borrelia garinii – Borrelia bissettii – Borrelia bavariensis – Borrelia miyamotoi – Candidatus Borrelia tachyglossi – Borrelia valaisiana – Borrelia afzelii – Borrelia finlandensis – Borrelia recurrentis – Bartonella henselae – Bartonella bacilliformis – Bartonella vinsonii – Bartonella quintana – Babesia microti – Babesia bigemina – Babesia divergens – Babesia duncani – Babesia bovis

  • RGCC, the medical genetics company in Greece, has a nearly 98% specificity to the target genes for the above-mentioned infections. “Their treatment is uniquely tailored to each patient. RGCC has state-of-the-art equipment and technology which enables them to identify specific gene sequences of various infectious agents. RGCC’s unique verification process includes cross-referencing the main gene sequences with the information stored in an international genetics database. This makes it possible to have the most accurate SOT and to maximize the success of treatment” (RGCC Labs).

  • Each SOT treatment targets one specific strain of an infectious pathogen. If a patient has multiple strains or species, they will require multiple SOT infusions. For example, if a patient tests positive for multiple strains of Bartonella, they will need multiple SOT infusions – one for each positive strain of Bartonella.

  • The patient will need a positive confirmation of the pathogen that SOT is being considered for. This can be done through a blood draw scheduled at Full Circle Health. This positive lab test must be less than 6 months old. Upon a positive test result, another blood sample will be taken at Full Circle Health and sent to RGCC, a medical genetics company in Greece. It is with this sample that the lab identifies the main genetic sequence of the target replication genes, then creates a complementary oligonucleotide sequence to block replication.

    The lab will then send back the IV remedy as a freeze-dried specimen. Each SOT treatment will be given as an IV infusion.

  • Due to it being highly compatible with the patient, side effects are usually minimal. Some may experience herxing symptoms. Usually, these symptoms resolve within 24 to 48 hours but may last up to a week or longer in some patients.

Book Your Appointment Today

Our staff can help determine the best treatment plan for you. Simply contact us to schedule your first visit.